Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Endpoints for randomized controlled clinical trials for COVID-19 treatments

Clinical Trials(2020)10.1177/1740774520939938Source: DataRank Database

Endpoints for randomized controlled clinical trials for COVID-19 treatments is a research paper published in Clinical Trials (2020). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.59)OA: bronzeTopics (29)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Dean Follmann ORCID,Jing Wang ORCID,Franz Koenig,Lisa L. Korn,Christian Schoergenhofer

Live enrichment

PubMed:32674594 OpenAlex:https://openalex.org/W3036655389

national cancer institute

Grant: 75N91019D00024

national institutes of health

Grant: 75N91019F00130

medical research council

Grant: MC_UU_0002/14

Prof Jaki’s Senior Research Fellowship

Grant: NIHR-SRF-2015-08-001

FWCI

0.59

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

bronzeLicense: cc-by

journalhttps://journals.sagepub.com/doi/pdf/10.1177/1740774520939938

publisherhttps://journals.sagepub.com/doi/pdf/10.1177/1740774520939938

publisherhttps://journals.sagepub.com/doi/full-xml/10.1177/1740774520939938

journalhttps://doi.org/10.1177/1740774520939938

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32674594

Fields of Study

Advanced Causal Inference TechniquesCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impacts

MeSH Terms

BetacoronavirusCOVID-19SARS-CoV-2Antiviral AgentsHumansPneumonia, ViralRandomized Controlled Trials as TopicCoronavirus InfectionsPandemics

Keywords

Time pointCoronavirus disease 2019 (COVID-19)Clinical trialClinical endpointRandomized controlled trialSample size determinationSurrogate endpointStatistical powerEvent (particle physics)MedicineStatisticsDiseaseComputer scienceIntensive care medicineEconometricsMathematicsInternal medicine

Sustainable Development Goals

SDG 0: Good health and well-being